Burstable Editorial Team
NewsRamp Burstable Feed
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
15497 articles
Articles
Soligenix Reports Positive Extended Phase 2a Results for Psoriasis Treatment SGX302
Soligenix Inc. reported extended results from its ongoing Phase 2a trial evaluating SGX302 for mild-to-moderate psoriasis, including outcomes from an additional cohort treated with an optimized topical gel formulation. The gel demonstrated improvements across multiple clinical and quality-of-life measures, with results comp...
December 17, 2025Read more
CNS Pharmaceuticals Appoints Rami Levin as CEO to Advance Brain Cancer Pipeline
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has announced a leadership transition with Rami Levin, MBA, appointed as president and chief executive officer, effective January 1, 2026. Levin succeeds John Climaco, who has stepped down from the CEO role. The biopharmaceutical company focuses on developing treatments for primary an...
December 17, 2025Read more
Natural Graphite Emerges as Strategic Material Powering AI, Electrification and Advanced Manufacturing
Artificial intelligence, electrification and advanced materials are reshaping global industrial priorities, with natural graphite emerging as a strategic engineering material that powers electric vehicle batteries, reinforces data center resilience, shields defense systems and enables next-generation composites. This transi...
December 17, 2025Read more
Kairos Pharma Receives Clinical Trials Arena Award for Prostate Cancer Research
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, has been recognized with the 2025 Clinical Trials Arena Excellence Awards, specifically receiving the Research and Development Award for Advanced Prostate Cancer. This accolade underscores the company's progress in developing ENV-105 (caro...
December 17, 2025Read more
MAX Power Mining Secures $5 Million Strategic Investment from Vietnam-Based Partner for Saskatchewan Natural Hydrogen Exploration
MAX Power Mining Corp. has completed a non-brokered private placement raising $5 million in gross proceeds from Vietnam-based strategic partner Big Energy, an affiliate of Bitexco. This transaction represents the first significant investment by a Vietnamese company in Saskatchewan's resource sector and establishes a strateg...
December 17, 2025Read more
Oncotelic Therapeutics Advances Nanoparticle Drug Delivery for Cancer Therapies
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is advancing nanoparticle-based delivery strategies in oncology through its joint venture entity, leveraging its Deciparticle platform to reimagine how cancer therapies are administered. The company is applying ultra-small carrier technologies to elevate existing cancer treatments b...
December 17, 2025Read more
Federal Push for AI in Healthcare Sparks Debate Between Modernization and Caution
The integration of artificial intelligence into healthcare systems is accelerating under new federal policy directions, creating both opportunities for modernization and concerns about appropriate implementation. A major legislative push championed by U.S. President Donald Trump is encouraging states to adopt more AI techno...
December 17, 2025Read more
Xeriant Engages IBN to Enhance Corporate Communications for Advanced Materials Portfolio
Xeriant, Inc. (OTCQB: XERI), a technology company specializing in advanced and sustainable materials, has engaged InvestorWire (IBN) to support its corporate communications strategy. The partnership aims to enhance visibility for Xeriant's innovative portfolio, which includes next-generation aerospace and materials technolo...
December 17, 2025Read more
USP22 Biomarker Discovery May Predict Immunotherapy Resistance in Cancer Patients
Scientists at Northwestern Medicine have discovered a biological marker that predicts which cancer patients are more resistant to immunotherapy. The marker, dubbed USP22, also points to a potential treatment target for non-responders. Findings published in The Journal of Clinical Investigation have the potential to transfor...
December 17, 2025Read more
Copper Hoarding Trends Signal Continued Price Volatility Through 2026
Copper prices achieved multiple record highs throughout 2025, with analysts forecasting the rally could extend into 2026 due to complex market dynamics. The metal's value trajectory remains uncertain, influenced by both supply-side pressures and demand-side fluctuations that could trigger significant price swings with any m...
December 17, 2025Read more
Global Tungsten Demand Surges Beyond Western Markets, Almonty Industries CEO Reports
Tungsten concentrate, a scarce metal with diverse industrial applications, is experiencing unprecedented global demand that extends beyond traditional Western markets, according to Almonty Industries Inc. CEO Lewis Black. During a recent interview on Benzinga All Access, Black revealed that tungsten prices have remained hig...
December 17, 2025Read more
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial, Addressing U.S. Supply Vulnerabilities
GeoVax Labs, Inc. has announced the successful completion of fill-finish for the initial clinical batch of GEO-MVA, its next-generation Mpox and smallpox vaccine. The product has entered final release evaluation, the concluding quality-control process required before clinical use, positioning the company for Phase 3 immunob...
December 17, 2025Read more
Lexston Mining Corporation Appoints Veteran Geologist Buddy Doyle to Advisory Board and Announces Stock Option Grant
Lexston Mining Corporation has appointed Buddy Doyle to its newly established Advisory Board, bringing four decades of mineral exploration experience to the company. Mr. Doyle's career includes over 23 years at Rio Tinto PLC, where he most recently served as Exploration Vice President of Kennecott Canada Exploration Inc., o...
December 17, 2025Read more
Moon Pursuit Capital Launches $100 Million Market-Neutral Crypto Fund for Institutional Investors
Moon Pursuit Capital announced the launch of its second fund, a $100 million market-neutral quantitative crypto fund structured for institutional allocators seeking asymmetric upside with lower volatility exposure. The digital asset investment firm's new vehicle represents a sophisticated approach to navigating cryptocurren...
December 17, 2025Read more
Birchtech Seeks $160 Million Patent Award to Fuel Water Purification Expansion
Birchtech Corp., parent company of clean air technology firm ME2C and water purification division WE2C, is preparing for a pivotal financial boost from a patent lawsuit that could transform its business trajectory. During a recent interview with Benzinga All Access, founder, President and CEO Richard MacPherson revealed the...
December 17, 2025Read more
Critical Infrastructure Technologies and Aegis Critical Energy Defence Corp. Sign Confidentiality Agreement to Explore Secure Energy and Digital Platform Collaboration
Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V), a developer of autonomous, high-capacity mobile communications and security platforms, has executed a Non-Disclosure Agreement with Aegis Critical Energy Defence Corp., a Canadian energy technology company specializing in advanced battery energy ...
December 17, 2025Read more
NeuroOne Reports Record Fiscal 2025 Results with 907% Q4 Revenue Growth and FDA Clearance for New Pain Treatment System
NeuroOne Medical Technologies Corporation reported substantial financial growth for its fourth quarter and fiscal year ended September 30, 2025, with product revenue increasing 907% to $2.7 million in the fourth quarter and 163% to $9.1 million for the full fiscal year. The medical technology company, which focuses on trans...
December 17, 2025Read more
ReelTime Media Showcases Comprehensive AI Platform During Fox News Streaming Broadcast
ReelTime Media, Inc. announced that audiences watching Fox News via streaming saw content created entirely by its proprietary Reel Intelligence platform, highlighting a significant development in artificial intelligence technology as streaming now accounts for nearly half of all U.S. television consumption. The spot feature...
December 17, 2025Read more
Intellum and Studion Partner to Deliver Scalable, Engaging Digital Learning Solutions
Intellum teams with Studion to combine scalable AI‐first learning delivery with custom digital learning design, bringing enterprise learning to life with high engagement and measurable impact.
December 17, 2025Read more
Search Atlas Integrates AI to Transform SEO Strategies for Businesses
Search Atlas is transforming how businesses approach search engine optimization by integrating advanced artificial intelligence features into its platform. This development addresses the growing need for effective SEO strategies as digital landscapes evolve and competition for online visibility intensifies. The AI-powered t...
December 17, 2025Read more
New Book Offers Practical Framework for Maintaining Balance in Demanding Modern Life
In an era characterized by constant demands and increasing pressure to perform, many individuals achieve external success while experiencing internal strain. Dr. Dennis O. Mims addresses this contemporary tension in his new book 'Keeping Life in Balance,' which offers a reflective exploration of how people can live intentio...
December 17, 2025Read more